An experimental drug for Alzheimer's disease is showing early promise, according to research reported in the journal Nature.

[JAMMY]

http://www.nbcdfw.com/news/local/Experimental-Drug-for-Alzheimers-Disease-Shows-Progress-392083811.html

Drug maker Biogen developed the drug called Aducanumab and funded the latest research. The drug was found to significantly reduce toxic plaques in the brain, which experts believe play a critical role in the development of Alzheimer's. It also seemed to slow down the loss of memory and thinking, says researchers. Dr. Cindy Marshall, Medical Director at Baylor AT&T Memory Center says "there's a great deal of debate about what the actual cause and cascade of Alzheimer's is, but one of the targets for treatment is to eliminate the plaques or to prevent the production of the abnormal plaques in the first place."

Source: Experimental Drug for Alzheimer's Disease Shows Progress | NBC 5 Dallas-Fort Worth http://www.nbcdfw.com/news/local/Experimental-Drug-for-Alzheimers-Disease-Shows-Progress-392083811.html#ixzz4J5cszYCH
Follow us: @nbcdfw on Twitter | NBCDFW on Facebook